After many years of collaboration through his previous employer, Daniel Pelke joined fme in 2015 as Business Unit Director in the Life Sciences division. He was appointed to the Management Board in 2017 and supported the digital transformation of fme clients together with Dirk Bode, who had already been the sole member of the Management Board for six years at the time. With his commitment, creativity and pragmatic approach, Daniel Pelke has not only driven forward the digital transformation of clients during his time at fme, but has also provided inspiration for the company’s internal development.
The decision to end the contract term early was made jointly in order to optimally align internal processes with the strategic development of the company. Daniel Pelke’s responsibilities will be taken over by Dirk Bode, CEO of fme AG, in the future.